Prelude Capital Management’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-26,796
Closed -$1K 2166
2022
Q2
$1K Hold
26,796
﹤0.01% 1786
2022
Q1
$4K Hold
26,796
﹤0.01% 1706
2021
Q4
$13K Hold
26,796
﹤0.01% 1868
2021
Q3
$15K Hold
26,796
﹤0.01% 1606
2021
Q2
$19K Buy
+26,796
New +$15.8K ﹤0.01% 1551

Prelude Capital Management's ISLEW Position: Q3 2022 in Review

Prelude Capital Management sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q3 2022, closing a stake of 26,796 shares — an estimated $1K sold.

Prelude Capital Management first reported a position in ISLEW in Q2 2021 and held it in 5 quarters. The position peaked at $19K in Q2 2021. 0 funds tracked by Wall St. Rank hold ISLEW as of Q3 2022.

  • Prelude Capital Management reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • Prelude Capital Management sold 26,796 Isleworth Healthcare Acquisition Corporation Warrant shares in Q3 2022, an estimated $1K.
  • Prelude Capital Management first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q2 2021 and held it in 5 quarters.
  • Prelude Capital Management's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $19K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q3 2022.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.